Search
for
Sort by
Research 421–450 of 1000+
- Skin signs in anorexia nervosa
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- The effect of menopause on the skin and other connective tissues
- Thyroid hormone action on skin
- Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation
- Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone
- Mood disorders and quality of life in polycystic ovary syndrome
- Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata
- The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Clinical efficacy and safety of low‐dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- THE EFFECT OF SPIRONOLACTONE ON HIRSUTISM AND FEMALE ANDROGEN METABOLISM
- A systematic review of antiandrogens and feminization in transgender women
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator
- Androgens Induce Nongenomic Stimulation of Colonic Contractile Activity through Induction of Calcium Sensitization and Phosphorylation of LC20 and CPI-17
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome
- Psychological aspects of hyperandrogenic states in late adolescent and young women
- Diagnostic approach to low‐renin hypertension
- Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- THE FIBROBLAST AS A MODEL FOR ANDROGEN RESISTANT STATES
- CHRONIC TREATMENT REGIMENS FOR HIRSUTISM IN WOMEN: EFFECT ON BLOOD PRODUCTION RATES OF TESTOSTERONE AND ON HAIR GROWTH
- Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women